These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
383 related articles for article (PubMed ID: 15781862)
21. p53 regulates Stat3 phosphorylation and DNA binding activity in human prostate cancer cells expressing constitutively active Stat3. Lin J; Tang H; Jin X; Jia G; Hsieh JT Oncogene; 2002 May; 21(19):3082-8. PubMed ID: 12082540 [TBL] [Abstract][Full Text] [Related]
22. Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells. Lin L; Hutzen B; Zuo M; Ball S; Deangelis S; Foust E; Pandit B; Ihnat MA; Shenoy SS; Kulp S; Li PK; Li C; Fuchs J; Lin J Cancer Res; 2010 Mar; 70(6):2445-54. PubMed ID: 20215512 [TBL] [Abstract][Full Text] [Related]
23. Stat3 upregulates MEK5 expression in human breast cancer cells. Song H; Jin X; Lin J Oncogene; 2004 Oct; 23(50):8301-9. PubMed ID: 15378007 [TBL] [Abstract][Full Text] [Related]
24. The interaction of specific peptide aptamers with the DNA binding domain and the dimerization domain of the transcription factor Stat3 inhibits transactivation and induces apoptosis in tumor cells. Nagel-Wolfrum K; Buerger C; Wittig I; Butz K; Hoppe-Seyler F; Groner B Mol Cancer Res; 2004 Mar; 2(3):170-82. PubMed ID: 15037656 [TBL] [Abstract][Full Text] [Related]
25. Epidermal growth factor receptor-independent constitutive activation of STAT3 in head and neck squamous cell carcinoma is mediated by the autocrine/paracrine stimulation of the interleukin 6/gp130 cytokine system. Sriuranpong V; Park JI; Amornphimoltham P; Patel V; Nelkin BD; Gutkind JS Cancer Res; 2003 Jun; 63(11):2948-56. PubMed ID: 12782602 [TBL] [Abstract][Full Text] [Related]
27. Requirement for Ras/Rac1-mediated p38 and c-Jun N-terminal kinase signaling in Stat3 transcriptional activity induced by the Src oncoprotein. Turkson J; Bowman T; Adnane J; Zhang Y; Djeu JY; Sekharam M; Frank DA; Holzman LB; Wu J; Sebti S; Jove R Mol Cell Biol; 1999 Nov; 19(11):7519-28. PubMed ID: 10523640 [TBL] [Abstract][Full Text] [Related]
28. Cryptotanshinone inhibits constitutive signal transducer and activator of transcription 3 function through blocking the dimerization in DU145 prostate cancer cells. Shin DS; Kim HN; Shin KD; Yoon YJ; Kim SJ; Han DC; Kwon BM Cancer Res; 2009 Jan; 69(1):193-202. PubMed ID: 19118003 [TBL] [Abstract][Full Text] [Related]
29. Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer. Toyonaga T; Nakano K; Nagano M; Zhao G; Yamaguchi K; Kuroki S; Eguchi T; Chijiiwa K; Tsuneyoshi M; Tanaka M Cancer Lett; 2003 Nov; 201(1):107-16. PubMed ID: 14580692 [TBL] [Abstract][Full Text] [Related]
30. Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. Schust J; Sperl B; Hollis A; Mayer TU; Berg T Chem Biol; 2006 Nov; 13(11):1235-42. PubMed ID: 17114005 [TBL] [Abstract][Full Text] [Related]